Obeticholic acid combined with ursodeoxycholic acid and fibrates as a second-line therapy in patients with difficult-to-treat primary biliary cholangitis: A retrospective multicenter cohort study
Latest Information Update: 01 Apr 2021
At a glance
- Drugs Bezafibrate (Primary) ; Fenofibrate (Primary) ; Obeticholic acid (Primary) ; Ursodeoxycholic acid (Primary)
- Indications Primary biliary cirrhosis
- Focus Proof of concept; Therapeutic Use
- 01 Apr 2021 New trial record
- 25 Mar 2021 Results published in the Alimentary Pharmacology and Therapeutics